Glycemia control and glucose-lowering therapy in patients with type 2 diabetes mellitus and cardiovascular disease (review of multicenter randomized trials)
The use of modern pharmaceuticals and cardiovascular disease (CVD) treatment methods has increased life expectancy and improved the quality of life of both patients with normal carbohydrate metabolism and diabetes mellitus (DM). This study provides a review of the literature on glycaemic control and...
Main Authors: | Sergey V. Kakorin, Ruben A. Iskandaryan, Ashot M. Mkrtumyan |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2016-06-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://dia-endojournals.ru/dia/article/viewFile/7564/5869 |
Similar Items
-
Hypoglycemic therapy in patients with type 2 diabetes and chronic heart failure
by: S. V Kakorin, et al.
Published: (2014-03-01) -
Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials
by: Sergey V. Kakorin, et al.
Published: (2016-04-01) -
Chronic heart failure in patients with type 2 diabetes mellitus: prevalence, prognosis
by: S. V Kakorin, et al.
Published: (2015-03-01) -
Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes
by: Kiyohiko Takahashi, et al.
Published: (2019-03-01) -
Review of the cardiovascular safety of dipeptidyl peptidase-4 inhibitors and the clinical relevance of the CAROLINA trial
by: Marile Santamarina, et al.
Published: (2019-03-01)